Neuraxpharm Allies With Panaxia On Cannabis Portfolio

Launching In Germany, With Other European Countries To Follow

CNS specialist Neuraxpharm has struck a deal with Israel’s Panaxia to market medical cannabis products in Europe, starting in Germany.

Germany_Cannabis
Neuraxpharm has struck a deal to enter Germany with Panaxia’s cannabis products • Source: Shutterstock

Neuraxpharm, the Germany-based central nervous system specialist, has struck a deal that will see it market domestically a range of medical cannabis products made by Israel’s Panaxia Labs.

The collaboration will start in Germany – which Neuraxpharm said was “Europe’s largest cannabis market” – but was “expected to...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business